Pharmaceutical compositions, containing micronized-tanaproget, or pharmaceutically acceptable salt thereof, microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, butylafced hydroxyanisole, povidone, and magnesium stearate, are provided. In addition processes of manufacturing are described.